As of April 29, 2025, Cyclerion Therapeutics (CYCN) has a market cap of $8.529 million USD. According to our data, Cyclerion Therapeutics is ranked No.8871 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $8.53 M |
-2.27%
|
Dec 31, 2024 | $8.73 M |
-3.88%
|
Dec 29, 2023 | $9.08 M |
-74.47%
|
Dec 30, 2022 | $35.56 M |
-61.86%
|
Dec 31, 2021 | $93.23 M |
-43.79%
|
Dec 31, 2020 | $0.17 B |
12.50%
|
Dec 31, 2019 | $0.15 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Vertex Pharmaceuticals
VRTX
|
$127.64 B |
0.004 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.59 B |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
![]() USA
|
![]() Amgen
AMGN
|
$152.20 B |
0.126 B
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$62.20 B |
1.034 B
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.98 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$33.29 B |
-0.001 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$12.13 B |
0.000 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.74 B |
0.000 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.76 B |
0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.69 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.34 M |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.23 B |
-0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.13 B |
0.000 M
|
![]() USA
|
Market Cap | = | CYCN Stock Price | * | CYCN Shares Outstanding |
= | $3.35 | * | 2.55 M | |
= | $8.53 M |